Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Robert Coleman Lindsley, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by Robert Lindsley and Daniel DeAngelo.
Connection Strength

0.807
  1. The clinical and functional effects of TERT variants in myelodysplastic syndrome. Blood. 2021 May 21.
    View in: PubMed
    Score: 0.250
  2. Systematic STAT3 sequencing in patients with unexplained cytopenias identifies unsuspected large granular lymphocytic leukemia. Blood Adv. 2017 Sep 26; 1(21):1786-1789.
    View in: PubMed
    Score: 0.193
  3. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood. 2015 Feb 26; 125(9):1367-76.
    View in: PubMed
    Score: 0.160
  4. Pretreatment clinical and genetic factors predict early post-treatment mortality in fit AML patients following induction. Am J Hematol. 2021 Apr 10.
    View in: PubMed
    Score: 0.062
  5. Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial. Lancet Haematol. 2020 Feb; 7(2):e122-e133.
    View in: PubMed
    Score: 0.056
  6. Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemia. J Clin Invest. 2016 10 03; 126(10):3827-3836.
    View in: PubMed
    Score: 0.045
  7. The role of Lin28b in myeloid and mast cell differentiation and mast cell malignancy. Leukemia. 2015 Jun; 29(6):1320-30.
    View in: PubMed
    Score: 0.040
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.